EndoFlip
Device Motility Testing
PDI 05391530810050
General payments
$502,066
Research payments
$204,101
Through program year 2025, $502,066 in general payments and $204,101 in research payments were reported against EndoFlip (Motility Testing).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $134,567 | 689 |
| 2025 | Research | $3,550 | 2 |
| 2024 | General | $74,127 | 801 |
| 2024 | Research | $174,363 | 25 |
| 2023 | General | $69,682 | 792 |
| 2023 | Research | $4,296 | 1 |
| 2022 | General | $78,452 | 969 |
| 2022 | Research | $1,385 | 1 |
| 2021 | General | $145,237 | 461 |
| 2021 | Research | $20,507 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,712 general · 34 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.